Opinion: Meaningful drug pricing reforms are headed nowhere fast
President Biden is taking a page out of former President Trump’s drug pricing playbook: offer big promises around tough negotiations with drugmakers, but fail to offer a viable path for getting it done.
Warning signs that drug pricing would no longer be a priority for the president’s marquee legislation came over the past week from the Washington Post and Wall Street Journal. To the chagrin of House Speaker Nancy Pelosi (D-CA) and other Democrats, President Biden’s massive, $1.8 trillion social safety net plan to help American families, details of which were unveiled Wednesday morning, does not include a major push to curtail drug prices.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.